![James Cummings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Cummings
Chief Tech/Sci/R&D Officer at
VAXART, INC.
Net worth: 261 714 $ as of 2026-06-29
Profile
Dr. James F.
Cummings, MD, is a Chief Medical Officer at Vaxart, Inc. Dr. Cummings was previously employed as a President & Chief Executive Officer by ICON Government & Public Health Solutions, Inc., a VP-Clinical Development & Translational Medicine by Novavax, Inc., a Director-Defense Department by Global Emerging Infectious Surveillance & Response System, and a Director-Translational Medicine by Walter Reed Army Institute of Research.
He also served on the board at OyaGen, Inc. He received his undergraduate degree from Georgetown University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAXART, INC. 0.18% | 2026-05-25 | 432,585 ( 0.18% ) | 261 714 $ | 2026-06-29 |
James Cummings active positions
| Companies | Position | Start |
|---|---|---|
| VAXART, INC. | Chief Tech/Sci/R&D Officer | 2021-09-26 |
Former positions of James Cummings
| Companies | Position | End |
|---|---|---|
ICON Government & Public Health Solutions, Inc.
 ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Chief Executive Officer | 2021-08-31 |
| NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 2017-12-31 |
Global Emerging Infectious Surveillance & Response System | Corporate Officer/Principal | 2015-07-31 |
Walter Reed Army Institute of Research | Corporate Officer/Principal | 2009-02-28 |
OyaGen, Inc.
 OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Director/Board Member | - |
Training of James Cummings
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
34
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
OyaGen, Inc.
OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Health Technology |
ICON Government & Public Health Solutions, Inc.
ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Commercial Services |
Walter Reed Army Institute of Research | Electronic Technology |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Global Emerging Infectious Surveillance & Response System |
- Stock Market
- Insiders
- James Cummings
